BP000447-HIV-107: Recombinant HTLV-1 Envelope
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HTLV-I and HTLV-II infected individuals with antibody response to HTLV envelope.
Purity > 95%, by 10% PAGE and RP-HPLC.
Applications: WB, ELISA.BP000447-HIV-115: Recombinant HTLV-1 + 2
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.
Applications: WB, ELISA.BP000447-HIV-003: Recombinant HTLV-1 p24
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000447-HIV-108: Recombinant HTLV-1 p24 Core
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HTLV-1 infected individuals.
Purity > 95%, by 10% PAGE and RP-HPLC.
Applications: WB, ELISA.BP000425-HSV-222: Recombinant HSV-2 gD
Source: E. coli-derived.
Specificity: Immunoreactive with sera of HSV-infected individuals.
Purity>95.0% by 10% PAGE.
Applications: WB, ELISA.BP000425-HSV-220: HSV-2 gG
Specificity: Immunoreactive with sera of HSV-infected individuals.
Purity>99.0% by Analytical HPLC and Mass Spec.
Applications: WB, ELISA.BP000425-HSV-223: Recombinant HSV-2 gG
Source: E. coli-derived.
Specificity: Immunoreactive with sera of HSV-infected individuals.
Purity>95.0% by 10% PAGE.
Applications: WB, ELISA.BP000424-HSV-224: Recombinant HSV-1 gG
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WB, ELISA.BP000424-HSV-221: Recombinant HSV-1 gD
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WB, ELISA.BP000444-HIV-151: Recombinant HIV-2 gp36, MBP Tag
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.